SmallCap
CompaniesMapStatistics

(주)제넷바이오

Venture Certified
Data Quality: 8/10

Basic Information


Unlisted

Company Name(주)제넷바이오
Business Reg. No.3088129477
CEO이시흥
Address대전광역시 유성구
Industry그 외 기타 분류 안된 화학제품 제조업
Industry Code20499
Main Products생명공학용 시약, 진단시약
EstablishedContact
Phone042-361-****
WebsiteContact
Regular EmployeesContact
Corp. Reg. No.161311-*******

Investment Metrics


Market Cap
-
Op. Margin
-0.88%
ROE
-6.72%
Debt Ratio
100.43%

Certification Status


Venture Certified

Cert. History
신기술기업(고도기술수반산업)2006-01-13 ~ 2008-01-1261522032100020-
연구개발유형2008-01-13 ~ 2010-01-12200804000552008-02-15
연구개발유형2010-01-13 ~ 2012-01-12201004001192008-02-15
기술평가보증기업(기금)2012-06-07 ~ 2014-06-06201201052522008-02-15
기술평가보증기업(기금)2014-06-07 ~ 2016-06-06201401080452008-02-15
기술평가보증기업(기금)2016-06-07 ~ 2018-06-06201601085032008-02-15
기술평가보증기업(기금)2018-06-07 ~ 2020-06-06201801072032008-02-15
연구개발유형2020-06-07 ~ 2022-06-06202001068552008-02-15
연구개발유형2022-06-07 ~ 2025-06-06202208180200192008-02-15
연구개발유형2025-06-07 ~ 2028-06-06202507080200132008-02-15

Financial Statements


3-Year Financial Data

Revenue CAGR -20.0%

Item202420232022
Revenue

21B

20B

33B

Operating Profit

-0.2B

-0.6B

8.5B

Net Profit

-2.1B

-1.6B

8.8B

Total Assets

63B

66B

70B

Total Liabilities

32B

32B

33B

Total Equity

32B

34B

37B

Risk Indicators


2 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
21B

20.5%

vs. 3-Year Avg.: 26B
Operating Profit
-1,85010K

104.7%

vs. 3-Year Avg.: 4B
Op. Margin
-0.9%

107.7%

vs. 3-Year Avg.: 11.4%
Debt Ratio
100.4%

8.0%

vs. 3-Year Avg.: 93.0%
ROE
-6.7%

170.1%

vs. 3-Year Avg.: 9.6%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
이시흥대표이사대표

Employment Status


Regular EmployeesContact
CEO이시흥

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


1 Additional Data Sources

{
  "address": "대전광역시 유성구",
  "ceo_name": "이시흥",
  "certificate": [
    {
      "cert_number": "61522032100020",
      "changes": "",
      "disclosure_date": "2006-01-13",
      "first_cert_date": "",
      "no": "1",
      "type": "신기술기업(고도기술수반산업)",
      "valid_period": "2006-01-13 ~ 2008-01-12"
    },
    {
      "cert_number": "20080400055",
      "changes": "",
      "disclosure_date": "2008-02-15",
      "first_cert_date": "2008-02-15",
      "no": "2",
      "type": "연구개발유형",
      "valid_period": "2008-01-13 ~ 2010-01-12"
    },
    {
      "cert_number": "20100400119",
      "changes": "",
      "disclosure_date": "2010-03-08",
      "first_cert_date": "2008-02-15",
      "no": "3",
      "type": "연구개발유형",
      "valid_period": "2010-01-13 ~ 2012-01-12"
    },
    {
      "cert_number": "20120105252",
      "changes": "",
      "disclosure_date": "2012-06-07",
      "first_cert_date": "2008-02-15",
      "no": "4",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2012-06-07 ~ 2014-06-06"
    },
    {
      "cert_number": "20140108045",
      "changes": "",
      "disclosure_date": "2014-07-04",
      "first_cert_date": "2008-02-15",
      "no": "5",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2014-06-07 ~ 2016-06-06"
    },
    {
      "cert_number": "20160108503",
      "changes": "",
      "disclosure_date": "2016-07-14",
      "first_cert_date": "2008-02-15",
      "no": "6",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2016-06-07 ~ 2018-06-06"
    },
    {
      "cert_number": "20180107203",
      "changes": "",
      "disclosure_date": "2018-06-12",
      "first_cert_date": "2008-02-15",
      "no": "7",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2018-06-07 ~ 2020-06-06"
    },
    {
      "cert_number": "20200106855",
      "changes": "",
      "disclosure_date": "2020-05-26",
      "first_cert_date": "2008-02-15",
      "no": "8",
      "type": "연구개발유형",
      "valid_period": "2020-06-07 ~ 2022-06-06"
    },
    {
      "cert_number": "20220818020019",
      "changes": "",
      "disclosure_date": "2022-08-18",
      "first_cert_date": "2008-02-15",
      "no": "9",
      "type": "연구개발유형",
      "valid_period": "2022-06-07 ~ 2025-06-06"
    },
    {
      "cert_number": "20250708020013",
      "changes": "",
      "disclosure_date": "2025-07-08",
      "first_cert_date": "2008-02-15",
      "no": "10",
      "type": "연구개발유형",
      "valid_period": "2025-06-07 ~ 2028-06-06"
    }
  ],
  "company_name": "(주)제넷바이오",
  "corp_no": "161311-*******",
  "financials": {
    "2022": {
      "capital_stock": 50000000,
      "cost_of_sales": 1359055000,
      "current_assets": 1472929000,
      "current_liabilities": 372687000,
      "gross_profit": 1933006000,
      "net_income": 883469000,
      "net_income_bs": 743148000,
      "non_current_assets": 5554823000,
      "non_current_liabilities": 2970000000,
      "non_operating_expenses": 171033000,
      "non_operating_income": 205909000,
      "operating_profit": 848593000,
      "revenue": 3292061000,
      "sga_expenses": 1084413000,
      "total_assets": 7027752000,
      "total_equity": 3685065000,
      "total_liabilities": 3342687000
    },
    "2023": {
      "capital_stock": 50000000,
      "cost_of_sales": 813414000,
      "current_assets": 1501523000,
      "current_liabilities": 188094000,
      "gross_profit": 1193691000,
      "net_income": -161993000,
      "net_income_bs": -161993000,
      "non_current_assets": 5082643000,
      "non_current_liabilities": 3023000000,
      "non_operating_expenses": 136274000,
      "non_operating_income": 35735000,
      "operating_profit": -61454000,
      "revenue": 2007105000,
      "sga_expenses": 1255145000,
      "total_assets": 6584166000,
      "total_equity": 3373072000,
      "total_liabilities": 3211094000
    },
    "2024": {
      "capital_stock": 50000000,
      "cost_of_sales": 950531000,
      "current_assets": 1621875000,
      "current_liabilities": 151365000,
      "gross_profit": 1156231000,
      "net_income": -212295000,
      "net_income_bs": -212295000,
      "non_current_assets": 4713267000,
      "non_current_liabilities": 3023000000,
      "non_operating_expenses": 226270000,
      "non_operating_income": 32470000,
      "operating_profit": -18495000,
      "revenue": 2106762000,
      "sga_expenses": 1174726000,
      "total_assets": 6335142000,
      "total_equity": 3160777000,
      "total_liabilities": 3174365000
    }
  },
  "industry": "그 외 기타 분류 안된 화학제품 제조업",
  "investment": [],
  "main_products": "생명공학용 시약, 진단시약",
  "phone": "042-361-****",
  "years": [
    2024,
    2023,
    2022
  ]
}

Data Sources


Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8

Data Sources by Section
SectionSource:Status
Basic InfoPublic Data
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersPublic Data
Collected
EmploymentNot Collected
Not Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Venture System Detail2026-02-25
Collected